Novartis AG - doses sold for prevention of major diseases 2013

This statistic depicts the number of doses sold by Novartis AG for the prevention of major diseases in 2013. Novartis AG is one of the largest pharmaceutical companies and is based in Basel, Switzerland. In that year, Novartis sold more than 63 million doses for the prevention of seasonal influenza, including the products Fluad, Fluvirin, Agrippal, Agriflu, Flucelvax, and Optaflu.

Doses sold by Novartis AG for the prevention of major diseases in 2013

Number of doses in millions
Seasonal influenza63.1
Meningitis23.9
Pandemic influenza19.7
Rabies7.5
Encephalitis1.6
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2014

Region

Worldwide

Survey time period

2013

Supplementary notes

Seasonal influenza: Fluad, Fluvirin, Agrippal, Agriflu, Flucelvax, Optaflu
Meningitis: Menveo, Menjugate
Pandemic influenza: Celtura, Focetria, Aflunov, H1N9 vaccine, H7N9 vaccine
Rabies: Rabipur, Rabavert
Encephalitis: Ixiaro; in collaboration with Valneva

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.